Navigation Links
Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story
Date:4/16/2008

Patients Need A Biogenerics Pathway that DOESN'T Keep Them Waiting

WASHINGTON, April 16 /PRNewswire-USNewswire/ -- With dozens of biotech and drug company CEOs flying to Capitol Hill to meet with members of Congress, The Coalition for a Competitive Pharmaceutical Market (CCPM) today released a new ad urging members to keep the best interests of patients in mind as they consider legislation to create a workable approval pathway for safe, effective and affordable biogeneric medicines.

The ad, "What If Patients Had Wings?," states that meaningful biogenerics legislation should ensure that patients have access to life saving biogeneric medicines sooner rather than later. Such legislation must strike the balance of fostering innovation without harming patient access through excessive and unprecedented market exclusivity which simply extends brand monopolies and stifles competition. A bill that does not achieve this objective will be an empty promise to patients.

A broad coalition of patients, seniors, consumers, businesses, labor, pharmacists, health plans, pharmacy benefit managers, and generics supplemented this effort by sending a letter to House Energy and Commerce Committee Chairman John Dingell and Ranking Member Joe Barton reiterating its principles for workable and balanced biogenerics legislation that:

1. Empowers the FDA to use its expertise to determine on a case by case

basis what scientific data they need to approve comparable and

interchangeable products.

2. Does not include administrative barriers that impede FDA's ability to

approve safe and effective biogenerics.

3. Provides a clear framework for interchangeability that is immediately

operative and does not require additional congressional action.

4. Ensures predictability for when scientifically-proven, safe and

effective biogenerics can enter the marketplace.

5. Provides a clear and timely resolution to patent disputes and

prohibits frivolous suits that restrict access to biogenerics and

delay competition in the marketplace.

6. Creates a balanced process that encourages innovation by both brand

and generic companies and expands access to prescription medications

for consumers.

7. Does not create a system of endless monopoly pricing and no

opportunity for competition to enter the marketplace.

The following is the text of the latest CCPM ad:

What If Patients Had Wings?

Executives from the multi-billion dollar pharmaceutical and biotech

industry are descending on Congress...flying to Washington to make sure

their monopolies are protected.

Meanwhile countless Americans are struggling to pay for high-priced

biopharmaceutical medicines.

These patients can't fly to Washington on their own, but they are making

their voices heard.

Numerous organizations representing patients, seniors, consumers, labor,

and businesses support legislation to establish a workable approval

pathway for biogenerics.

Americans need balanced legislation that fosters innovation without

excessive market exclusivity which does nothing more than extend

monopolies, stifle competition and keep patients waiting for affordable

medicines.

BIO and PhRMA say that want a biogenerics pathway, but their policy is an

empty promise to patients.

CCPM supports public policies that facilitate timely access to affordable pharmaceuticals. Visit http://www.competitiverx.com for more information and a list of CCPM members.

Contact: Katie Braden Huffard, 202-255-5216;

Andrea Hofelich, 703-647-2495; Charles Cote, 202-207-3605


'/>"/>
SOURCE The Coalition for a Competitive Pharmaceutical Market(CCPM)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
2. FrontPath Health Coalition To Lead Community-wide Group in Pilot Program
3. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
4. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
5. Agendia Joins the Personalized Medicine Coalition (PMC)
6. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
7. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
8. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
9. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
10. Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News
11. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Aug. 15, 2017 After spending the past two years ... crowdsourced data collection, GeneFo now offers this platform to healthcare stakeholders ... amplifying support, adherence, and data collection vis a vis their members, ... the successful launch of this offer. ... GeneFo ...
(Date:8/15/2017)... San Diego, CA (PRWEB) , ... August 15, ... ... science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the ... reduces the number of steps needed to gain kinetic binding data for a ...
(Date:8/15/2017)... MA (PRWEB) , ... August 15, 2017 , ... Any ... need that has compromised these disciplines for more than half a century. Despite ... be counted. It is widely known that molecular tags developed for this purpose ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum and ... (IO360°) programming through a series of upcoming panels and events. The partnership culminates with ... The Roosevelt Hotel in New York City. , “With our experience in producing the ...
Breaking Biology Technology:
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology News(10 mins):